Clinical Trial Update: Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

View source ↗

Summary

The GREAT1.0 genomic resources study is currently suspended, with no trial results reported at this time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease
• Chronic Kidney Disease
• Crohn Disease
• Inflammatory Bowel Disease
• Irritable Bowel Syndrome
• Nonalcoholic Steatohepatitis
• Pancreatitis
• Viral Hepatitis

Snippet

Sponsor: University of Pittsburgh | Conditions: Chronic Pancreatitis, Inflammatory Bowel Diseases | Status: SUSPENDED